about
Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls.Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
New agents on the horizon in gastric cancer.
@en
type
label
New agents on the horizon in gastric cancer.
@en
prefLabel
New agents on the horizon in gastric cancer.
@en
P2093
P2860
P356
P1433
P1476
New agents on the horizon in gastric cancer.
@en
P2093
Y Y Janjigian
P2860
P304
P356
10.1093/ANNONC/MDX051
P577
2017-02-09T00:00:00Z